Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
Lacey M. Litchfield(Eli Lilly (United States)), Iris L. Romero(University of Chicago)
Cited by 39
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Abemaciclib plus fulvestrant vs fulvestrant alone for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy: Primary outcome of the phase 3 postMONARCH trial.
|Journal of Clinical Oncology|2024|75
Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
|Cell Reports|2019|40
(untitled)
|Oncotarget|2020|1